American Headache Society & Pfizer Quality Improvement Competitive Grant Program- LOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: No RIS Review Required
External Deadline: Monday 5th, August 2024
Description
The American Headache Society strives to improve the lives of people impacted by migraine and other headache disorders. The AHS is a professional society of health care providers dedicated to the study and treatment of headache and face pain. The Society’s objective is to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals, and the public while encouraging scientific research are the primary functions of our Society. Learn more at AmericanHeadacheSociety.org.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in practice as outlined in the specific RFP.
For all quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.
Date RFP Issued: May 24, 2024
Geographic Scope: United States and Canada
NOTE: You must be a member of the American Headache Society in order to be eligible.
Clinical Area: Headache
Link to full RFP: American Headache Society & Pfizer Quality Improvement Competitive Grant Program
Letter of Intent (LOI) Due Date: August 5, 2024
Specific Area of Interest: This program seeks projects that will address quality gaps in headache medicine, with a goal of producing information or tools that can be widely used in the field and lead to measurable improvements in healthcare services for individuals with headache. Projects should also contribute to the core goal of the American Headache Society (AHS) – improving the lives of people impacted by migraine and other headache disorders.
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Angelo Carter, Grant Officer (Angelo.Carter@pfizer.com).